Press release
Alzheimer's Diagnosis and Drugs Market Projected to Reach USD 10.66 billion by 2030, Driven by Biomarker Diagnostics and Therapeutic Uptake
Alzheimer's Diagnosis and Drugs Market Size & Trends | Mordor Intelligence
Introduction
The Alzheimer's disease diagnostics and therapeutics market size stands at USD 8.13 billion in 2025 and is predicted to touch USD 10.66 billion by 2030, translating into a 5.57% CAGR during the forecast window. As the incidence of Alzheimer's disease rises and diagnostic and therapeutic options expand, stakeholders across the healthcare ecosystem are placing greater emphasis on early detection and drug development. This press release provides a detailed overview of the alzheimers diagnosis and drugs market size, its major trends, market segmentation, key players, and future outlook. The objective is to deliver actionable insights for business analysts, CXOs and strategic decision-makers who are monitoring the alzheimers diagnosis and drugs market growth and how it may influence investment and operational priorities.
Report Overview:
https://www.mordorintelligence.com/industry-reports/alzheimers-diagnosis-and-drugs-market?utm_source=openpr
Key Trends in the Alzheimer's Diagnosis and Drugs Market
In the context of the alzheimers diagnosis and drugs market analysis, a number of important trends are shaping market dynamics:
Wider adoption of blood-based biomarkers and imaging diagnostics: Growing use of biomarkers such as plasma phospho-tau assays and wider reimbursement for such tests are easing dependence on invasive or expensive diagnostics, thereby bolstering the diagnostics side of the alzheimers diagnosis and drugs market.
Approval of disease-modifying therapies: The arrival of anti-amyloid monoclonal antibodies and other therapeutic options has strengthened the drugs side of the market, supporting the overall alzheimers diagnosis and drugs market share held by therapeutics.
Shifting care settings and diagnostic pathways: There is a movement toward decentralised models such as home-care and remote testing, enabling broader access to diagnostics and maintenance therapy and influencing the growth trajectory of the alzheimers diagnosis and drugs market.
Regional growth disparities: While North America remains the largest region for the alzheimers diagnosis and drugs market, Asia-Pacific is emerging as the fastest-growing region, supported by increased healthcare investment and neurology capacity building.
Therapeutics versus diagnostics balance: Although therapeutics account for the majority of current revenues in this market, diagnostics are on a faster growth curve highlighting how the alzheimers diagnosis and drugs market trends are shifting toward earlier detection and intervention.
Together these trends underline that the alzheimers diagnosis and drugs market growth is being driven not only by the availability of treatments, but equally by diagnostics enabling early identification and management of Alzheimer's disease.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:https://www.mordorintelligence.com/ja/industry-reports/alzheimers-diagnosis-and-drugs-market?utm_source=openpr
Market Segmentation of the Alzheimer's Diagnosis and Drugs Market
The alzheimers diagnosis and drugs market segmentation is structured across product types, end users and geography. Below is a breakdown of the key segments:
By Product Type
By Product
Therapeutics
Cholinesterase Inhibitors
NMDA Receptor Antagonists
Anti-amyloid mAbs
Anti-tau & other DiMTs
Diagnostics
Brain Imaging
CSF Biomarker Tests
Blood-based Biomarker Tests
Genetic Testing
By End User
Hospitals & Specialty Clinics
Diagnostic Laboratories
Research & Academic Institutes
Homecare / Remote Testing Providers
By Geography
North America
Europe
Asia-Pacific
Middle East & Africa
South America
This segmentation lends clarity to decision-makers in understanding where value pools reside and where future opportunities are likely to emerge within the alzheimers diagnosis and drugs market.
Key Players in the Alzheimer's Diagnosis and Drugs Market
An overview of major companies influencing the landscape of the alzheimers diagnosis and drugs market:
AstraZeneca PLC
Johnson & Johnson
Eli Lilly and Company
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Explore more insights on alzheimers diagnosis and drugs market competitive landscape:https://www.mordorintelligence.com/industry-reports/alzheimers-diagnosis-and-drugs-market/companies?utm_source=openpr
Conclusion
The alzheimers diagnosis and drugs market is poised for meaningful expansion through to 2030, driven by the twin engines of diagnostic uptake and therapeutic innovation. The projected market size highlights a firm growth outlook for stakeholders who align with early-stage detection, drug development, and care-delivery transformation. As diagnostics become more accessible and therapies more effective, the alzheimers diagnosis and drugs market growth will not only reflect commercial potential but also the broader imperative of addressing an emerging global public-health challenge. For stakeholders from industry executives to healthcare payers and provider networks this is an opportunity to participate in a market where both patient outcomes and business performance can improve in parallel. With targeted investments and strategic execution, organisations will be well-positioned to capture value and play a meaningful role in the evolution of Alzheimer's care through to the forecast horizon.
For complete market analysis, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/alzheimers-diagnosis-and-drugs-market?utm_source=openpr
Industry Related Reports
Neurodegenerative Disease Market: The Neurodegenerative Disease Market is Segmented by Indication (Parkinson's Disease, and More), Drug Class (NMDA Receptor Antagonists, and More), Molecule Type (Small-Molecule Drugs, and More), Route of Administration (Oral, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, Asia-Pacific, and More).
Get More Insights: https://www.mordorintelligence.com/industry-reports/neurodegenerative-disease-market?utm_source=openpr
Dementia Drugs Market: The Dementia Therapeutics Market Report is Segmented by Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and More), Indication (Alzheimer's Disease, Parkinson's Disease Dementia, and More), Route of Administration (Oral, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, and More).
Get More Insights: https://www.mordorintelligence.com/industry-reports/dementia-drugs-market?utm_source=openpr
Neurological Disorder Drugs Market: The Neurological Disorder Drugs Market Report is Segmented by Indication (Alzheimer's Disease, Parkinson's Disease, and More), Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and More), Route of Administration (Oral, Intravenous, and More), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and More), and Geography (North America, and More).
Get More Insights:: https://www.mordorintelligence.com/industry-reports/neurological-disorder-drugs-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Diagnosis and Drugs Market Projected to Reach USD 10.66 billion by 2030, Driven by Biomarker Diagnostics and Therapeutic Uptake here
News-ID: 4260494 • Views: …
More Releases from Mordor Intelligence
China Residential Real Estate Market to Reach USD 2.92 Trillion by 2030, Fueled …
Mordor Intelligence has published a new report on the China Residential Real Estate Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
China Residential Real Estate Market Overview
The China Residential Real Estate Market size is valued at USD 2.76 trillion in 2025 and is projected to reach USD 2.92 trillion by 2030, growing at a CAGR of 1.12%. Large cities such as Shanghai lead in…
Textured Vegetable Protein Market Size to Reach USD 8.24 Billion by 2030 | Surge …
Introduction: Accelerating Shift Toward Sustainable and Protein-Rich Food Alternatives
The global textured vegetable protein (TVP) market is poised for significant expansion, estimated at USD 4.82 billion in 2025 and projected to reach USD 8.24 billion by 2030, registering a robust CAGR of 11.32% during the forecast period. The market's strong performance is driven by the rising demand for plant-based proteins, sustainable food sources, and consumer preference for healthier meat substitutes.…
Agricultural Microbials Market Size to Reach USD 14.30 Billion by 2030 | Rising …
Introduction: Microbial Innovations Transforming the Future of Global Agriculture
The agricultural microbials market size is estimated at USD 7.50 billion in 2025 and is expected to reach USD 14.30 billion by 2030, registering a strong CAGR of 13.8% during the forecast period (2025-2030). This growth underscores a global shift toward sustainable and biological farming solutions driven by soil health awareness, rising fertilizer prices, and increasing consumer preference for residue-free and…
North America Medium-Density Fiberboard Market growing at CAGR of 3.50%, Driven …
The latest research by Mordor Intelligence covers the "North America Medium-Density Fiberboard Market Size," delivering insights into market dynamics, drivers of growth, and long-term forecasts.
North America Medium-Density Fiberboard (MDF) market is on track to reach 8.62 million cubic meters by 2030, reflecting steady demand across residential, commercial, and institutional sectors. MDF, a versatile engineered wood product, continues to be a preferred choice for manufacturers and builders due to its uniform…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
